Drug Device Combination Products Market Will Report a Market Value Worth US$115 Billion by 2019: Transparency Market Research

News provided by

Transparency Market Research

05 Aug, 2015, 15:30 BST

ALBANY, New York, August 5, 2015 /PRNewswire/ --

A recent study by Transparency Market Research (TMR) forecasts that the global drug device combination products market will grow at a CAGR of 7.9% between the years 2013 to 2019. TMR, a market intelligence firm based in the United States, in its report says that the global drug device combination products market which was valued at US$66 billion in 2012 will report a market value worth US$115 billion by 2019. The report is titled "Drug Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Intraocular Implants and Drug Eluting Beads) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019".

Browse Market Research Report on Drug Device Combination Products Market: http://www.transparencymarketresearch.com/drug-device-combination.html

The global drug device combination products market is primarily driven by factors like rising incidence of cardiovascular diseases, pain causing anomalies, colorectal cancer, diabetic retinopathy, asthma, prostate cancer, the problem of obesity, and a rapidly growing geriatric population. Drug device combination products basically refer to individual products that comprise two regulated components, which are a medical device and an active pharmaceutical ingredient that are either physically or chemically combined for producing one product. The drugs that are present within the device are either surface coated or impregnated. Due to their usefulness in the area of advanced medical care, combination products these days are considered to be highly innovative medical products.

Get Sample Report Copy of Drug Device Combination Products Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534

The global drug device combination products market is segmented on the basis of its various types, and geography. On the basis of types, the global drug device combination products market is classified into infusion pumps, drug eluting stents, orthopedic combination products, photosensitizers, inhalers, wound care combination products, transdermal patches, and other drug device combination products. Peripheral vascular stents and coronary stents are the two sub categories under the drug eluting stents category. The different types of infusion pumps are ambulatory infusion pumps and implantable infusion pumps. Orthopedic combination products include bone graft implants and antibiotic bone cement. The different types of inhalers dominating the global drug device combination products market are dry powder inhalers, nebulizers, and metered dose inhalers. The other drug device combination products include drug eluting beads and intraocular implants. Latest technologies like implants with drugs that promote lesser morbidity, pain relief, and faster healing are expected to drive the global drug device combination products market in the forthcoming years.

Browse Press Release of Drug Device Combination Products Market: http://www.transparencymarketresearch.com/pressrelease/drug-device-combination.htm

From the regional perspective, the global drug device combination products market is dominated by North America in revenue terms. However, owing to rising incidence of diabetes, obesity, and cardiovascular diseases, the most lucrative market in the entire drug device combination products market is the Asia Pacific. The global drug device combination products market is expected to witness significant growth in the years to come owing to factors like rising demand for minimally invasive surgeries, NGO and government initiatives for promoting drug delivery implants, and increasing number of interventional cardiologists. A major growth restraint in this market is that of product recalls, due to adverse side effects to patients.

Other Reports by Transparency Market Research:  

Some of the key players operating in the global drug device combination products market are W. L. Gore & Associates, Inc., Terumo Corporation, Stryker Corporation, Pinnacle Biologics, Inc., Mylan, Inc., Medtronic, Inc., Medline Industries, Inc., Ethicon, Inc., C.R. Bard, Inc., Covidien PLC, and CareFusion Corporation.

Browse All Other Medical Devices Market Research Reports: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.europlat.org

SOURCE Transparency Market Research